Evidence map›Paper›PMID 34857890›Full record

ArticleCommunications biology2021

GFI1 tethers the NuRD complex to open and transcriptionally active chromatin in myeloid progenitors.

Anne Helness, Jennifer Fraszczak, Charles Joly-Beauparlant, Halil Bagci, Christian Trahan, Kaifee Arman, Peiman Shooshtarizadeh, Riyan Chen, Marina Ayoub, Jean-François Côté and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Anne HelnessInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Jennifer FraszczakInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Charles Joly-BeauparlantDépartement de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, QC, Canada.
Halil BagciInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Christian TrahanInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Kaifee ArmanInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.ORCID http://orcid.org/0000-0002-4667-4655
Peiman ShooshtarizadehInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Riyan ChenInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Marina AyoubInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Jean-François CôtéInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.ORCID http://orcid.org/0000-0001-7055-2642
Marlene OeffingerInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada.
Arnaud DroitDépartement de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, QC, Canada.ORCID http://orcid.org/0000-0001-7922-790X
Tarik MöröyInstitut de recherches cliniques de Montréal, Montréal, QC, H2W 1R7, Canada. Tarik.Moroy@ircm.qc.ca.ORCID http://orcid.org/0000-0003-4284-9849
Montreal Clinical Research Institute · CAUniversité Laval · CACentre Hospitalier Universitaire Sainte-Justine · CAETH Zurich · CH

Funding

CIHR FDN-148372CIHR MOP-84238CIHR MOP-94846CIHR PJT-153313
6 · The paper itself

Abstract

Growth factor indepdendent 1 (GFI1) is a SNAG-domain, DNA binding transcriptional repressor which controls myeloid differentiation through molecular mechanisms and co-factors that still remain to be clearly identified. Here we show that GFI1 associates with the chromodomain helicase DNA binding protein 4 (CHD4) and other components of the Nucleosome remodeling and deacetylase (NuRD) complex. In granulo-monocytic precursors, GFI1, CHD4 or GFI1/CHD4 complexes occupy sites enriched for histone marks associated with active transcription suggesting that GFI1 recruits the NuRD complex to target genes regulated by active or bivalent promoters and enhancers. GFI1 and GFI1/CHD4 complexes occupy promoters that are either enriched for IRF1 or SPI1 consensus binding sites, respectively. During neutrophil differentiation, chromatin closure and depletion of H3K4me2 occurs at different degrees depending on whether GFI1, CHD4 or both are present, indicating that GFI1 is more efficient in depleting of H3K4me2 and -me1 marks when associated with CHD4. Our data suggest that GFI1/CHD4 complexes regulate histone modifications differentially to enable regulation of target genes affecting immune response, nucleosome organization or cellular metabolic processes and that both the target gene specificity and the activity of GFI1 during myeloid differentiation depends on the presence of chromatin remodeling complexes.

Indexed as

Transcription, GeneticAnimalsChromatinDNA-Binding ProteinsMi-2 Nucleosome Remodeling and Deacetylase ComplexMiceMyeloid Progenitor CellsTranscription FactorsChromatinDNA-Binding ProteinsGfi1 protein, mouseMi-2 Nucleosome Remodeling and Deacetylase ComplexTranscription Factors

Identifiers

PMID34857890
PMCPMC8639993
OpenAlexW3170618908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.